Non-steroidal mineralocorticoid receptor antagonists

Intervention1 paper1 finding

Outcomes

1

Chronic kidney disease

downin humans1

1 study

  1. Non-steroidal mineralocorticoid receptor antagonists decrease chronic kidney disease in humans.

    Reviewin high-risk populations across the cardiovascular-kidney-metabolic spectrum

    Pharmacological treatment strategies to prevent heart failure across the cardiovascular-kidney-metabolic spectrum: an EJHF Expert Consensus Statement · European journal of heart failure · 1 Oct 2026

Chronic kidney disease →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11

Related